FDA Drug Application (021652) for EPZICOM by VIIV HLTHCARE

Back to FDA Applications sponsored by VIIV HLTHCARE

Application Number021652
Product Number001
FormTABLET;ORAL
DosageEQ 600MG BASE;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEPZICOM
Active IngredientABACAVIR SULFATE; LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR4
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by VIIV HLTHCARE